In vivo tau PET imaging in dementia: pathophysiology, radiotracer quantification, and a systematic review of clinical findings

B Hall, E Mak, S Cervenka, FI Aigbirhio, JB Rowe… - Ageing research …, 2017 - Elsevier
In addition to the deposition of β-amyloid plaques, neurofibrillary tangles composed of
aggregated hyperphosphorylated tau are one of the pathological hallmarks of Alzheimer's …

Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis

R Agarwal, CB Tripathi - American Journal of Alzheimer's …, 2014 - journals.sagepub.com
Background: Dementia is an age-related disorder associated with elderly population,
resulting from interaction of lifestyle risk factors with genetic, vascular, and other risk factors …

Associations between plasma biomarkers and cognition in patients with Alzheimer's disease and amnestic mild cognitive impairment: a cross-sectional and …

CL Tsai, CS Liang, JT Lee, MW Su, CC Lin… - Journal of Clinical …, 2019 - mdpi.com
Brain degeneration in patients with Alzheimer's disease (AD) results from the accumulation
of pathological amyloid-β (Aβ) plaques and tau protein tangles, leading to altered plasma …

Malignant brain aging: the formidable link between dysregulated signaling through mechanistic target of rapamycin pathways and alzheimer's disease (type 3 …

SM de la Monte - Journal of Alzheimer's Disease, 2023 - content.iospress.com
Malignant brain aging corresponds to accelerated age-related declines in brain functions
eventually derailing the self-sustaining forces that govern independent vitality. Malignant …

A systematic review and meta-analysis of plasma amyloid 1-42 and tau as biomarkers for Alzheimer's disease

KB Shanthi, S Krishnan, P Rani - SAGE open medicine, 2015 - journals.sagepub.com
Objective: Amyloid 1-42 (Aβ42) and tau in cerebrospinal fluid are currently used as markers
for diagnosis of Alzheimer's disease. Conflicting reports exist regarding their plasma levels …

Numerical simulations reveal randomness of Cu (II) induced Aβ peptide dimerization under conditions present in glutamatergic synapses

W Goch, W Bal - PLoS One, 2017 - journals.plos.org
The interactions between the Aβ1–40 molecules species and the copper ions (Cu (II)) were
intensively investigated due to their potential role in the development of the Alzheimer …

Early-Stage Moderate Alcohol Feeding Dysregulates Insulin-Related Metabolic Hormone Expression in the Brain: Potential Links to Neurodegeneration Including …

Y Yang, M Tong… - Journal of Alzheimer's …, 2024 - journals.sagepub.com
Background: Alzheimer's disease (AD), one of the most prevalent causes of dementia, is
mainly sporadic in occurrence but driven by aging and other cofactors. Studies suggest that …

Immunomagnetic Reduction Detects Plasma Aβ1–42 Levels as a Potential Dominant Indicator Predicting Cognitive Decline

SY Yang, HC Liu, WP Chen - Neurology and Therapy, 2020 - Springer
Although the concentrations of Alzheimer's disease (AD) biomarkers Aβ 1–40, Aβ 1–42 and
tau protein are very low in human plasma, ultrasensitive assays such as immunomagnetic …

[HTML][HTML] Analysis of apolipoprotein E genetic variation in patients with Alzheimer disease referred to Imam Reza Clinic, Rasht, Iran, in 2015

AR Ghayeghran, M Akbarshahi, Z Salehi… - Iranian Journal of …, 2017 - ncbi.nlm.nih.gov
Background: Alzheimer disease (AD) is a progressive neurological degenerative disorder
and the most common form of dementia. There are about 100 genes linked to AD including …

[引用][C] in vivo tau PET imaging in dementia: pathophysiology

B Hall, E Mak, S Cervenka - spectrum, 1931